LUTS/BPH Management Note

Date: [Date of encounter]

Patient: [Patient identifiers]

Visit Type: [new / established / consult; in-person / telehealth]

Referral Source/Reason: [Referring clinician and reason] (Only include if applicable)

Active Devices: [Urinary devices in place] (Omit if none)

History

Chief Concern: [Primary concern in patient-centered terms] (Use the patient's own words when available)

HPI: [Narrative history of present illness] (Include onset, time course, progression [stable / worsening / improving], and impact on quality of life. Document symptom domains: voiding symptoms [weak stream, hesitancy, intermittency, straining, terminal dribble], storage symptoms [frequency, urgency, urgency incontinence, nocturia], and post-micturition symptoms [incomplete emptying, post-void dribble]. Note any red flags if present: retention episodes, recurrent UTIs, gross hematuria, bladder stones, constitutional symptoms. Include patient goals for treatment.)

IPSS/AUA-SI: [Score (0–35), severity category (mild 0–7 / moderate 8–19 / severe 20–35), QoL/bother response, date obtained] (Include prior scores with dates for trend if available. If not completed, state "IPSS not completed" with clearly labeled clinician-estimated severity.)

Prior Therapies: [Behavioral measures tried and response; medication trials with drug/class, dose, duration, response, adverse effects, reason stopped; prior procedures with date, outcome, complications] (Provide concise timeline format when multiple trials present)

Relevant Context: [Medications affecting LUTS or therapy choice; key comorbidities influencing management] (Include orthostasis/fall risk, erectile/sexual goals, anticoagulation status, retention history, cognitive impairment as relevant)

Objective

Vitals: [Relevant vitals] (Include if pertinent to medication selection, e.g., BP for alpha-blocker consideration)

Exam: [Pertinent physical examination] (Abdomen for distension/palpable bladder; DRE with prostate size estimate, nodules/asymmetry, tenderness; neurologic exam only if neurogenic bladder suspected. If telehealth, state exam limitations.)

UA/Culture: [Results with date, or "pending" with follow-up plan]

PVR: [Value in mL, method (bladder scan / catheter), date, interpretation]

Uroflow: [Qmax (mL/s), voided volume, pattern, date] (If not performed, state reason if relevant to decision-making)

Prostate Size: [Volume estimate, date, source] (Include median lobe or obstructive features if reported)

PSA: [Most recent value(s) with dates and trend] (If ordering today, specify indication; if discussed as screening, summarize shared decision-making)

Assessment

[Working diagnosis with attribution] (State "LUTS most consistent with BPH/BPO" or "LUTS—etiology multifactorial" as appropriate. Include severity category and presence/absence of complications. List differential diagnoses only if clinical uncertainty exists.)

Plan

LUTS/BPH: [Management approach with rationale tied to symptom severity, objective data, and patient goals] (For conservative measures, specify recommendations. For medications, include agent/class, dose, expected time to benefit, key counseling, monitoring plan. For procedural pathway, document indication, anatomic parameters considered, options discussed with risks/benefits/alternatives, pre-procedure testing ordered. State follow-up interval and what will be reassessed. Include return precautions: acute retention, fever/flank pain, gross hematuria with clots, severe dizziness/syncope.)

Prostate Cancer Screening: [Shared decision-making summary, test ordered or deferred with rationale, follow-up plan] (Include only if addressed today)

Additional Problems: [Problem: Assessment — Plan] (Address other issues managed today as needed)

Orders: [Labs, imaging, procedures, referrals ordered]

Medications: [Started, changed, or stopped with dose/instructions/reason]

Patient Instructions: [Plain-language summary of plan, red flag symptoms, follow-up timing]

(If key decision-driving elements are unavailable, document explicitly: "IPSS not completed," "PVR not obtained—patient unable to void," "UA pending." Omit sections without encounter-relevant data rather than including boilerplate.)